Ubushakashatsi bw’ amashuri: Igihe ca Cannabis ku Isi, ugutera inkunga no kuyobora ishika – Ubutumwa kuzo Provinse ya Mwaro
Murakaza neza, inshuti zacu mu Provinse ya Mwaro.
Twaba OilWell Cannabis tubandikiye aha muu mujyi wa Houston muri Texas, dufise icyubahiro gihambaye kuri mwe, muryango wanyu no kubicaro byanyu mu gihugu ca Burundi. Ubutumwa dutanga uyu musi bushingiye kuga ukuri kw’ amashuri runaka. Turabizi ko amategeko atuma cannabis yemereka cyangwa ikumirwa atandukanye ahantu hose, kandi ntacyo biri ngaho uretse kudahamya ukuri ko mu gihugu canyu cannabis kibiragiwa.
Mu gihugu ca Burundi, na mbere mu provinsi ya Mwaro, cannabis igaragazwa nk’ ikibazo mu mategeko y’ igihugu. Nta gushaka, ubushobozi cyangwa ubushake dufite bwo gukangurira kubikora mu gihugu canyu bihambanye na mategeko ya Repubulika y’u Burundi. Intego yacu aha ntabwo ari ugushakisha abaguzi cyangwa kugurisha ibicuruzwa mu gihugu canyu, kuko ibyo byaba ari ibiteganyijwe n’amategeko. Ahubwo, twahawe ubumenyi buhana dore ko tu turi abashakashatsi ba cannabis, abakangurira kubazwa, no kwizera ko ubumenyi bushobora gutanga ibisobanuro ku biganiro bishya bikurikira kubyerekeye ibijyanye n’ ibiti by’ ubuvuzi, gusa mu bihugu ubu bigenzurwa.
Mu myaka irenga icumi ishize, intego yacu yasohotse mu kibazo kimwe gusa, cyahinduye uko tubona ico umuntu afite uburenganzira bwo kubona ibiti byiza by’ ubuvuzi bishobora kumufasha. Ni umugani wa Bentley, imbwa y’ umwihariye wacu, yahamwaye uburwayi budahumuriza, bisanza ko imfungwa mu kibazo cyo kurandura, nyuma y’uko irababara. Ubuvuzi bwa kera bw’ amatungo ntibwatanze ibisubizo bitari kugirango iyo imbwa yica. Ugushakisha ibindi bisubizo byahaye impamvu yo kubona CBD— kimwe mu byavuye mu mbuto z’ umusemburo, kitarazana ishavu. Dukoresheje inzira y’ umuti witwa “Golden Paste” udasanganira ibiti by’ ubuvuzi, amavuta y’ ingagi, urusenda kandi n’ amavuta ya CBD oil, Bentley yagize ibintu twumva nk’ ibyiza. Imbwa itashoboraga kugenda yahagaze, yagiye inoherereza agapira kayo gakunda. Yabayeho imyaka icumi irinzwe, ikazira mu buryo bwiza afite imyaka makumyabiri.
Icyo gikorwa gihambaye cyo gutsinda uburwayi budasanzwe ntacyo byaretse kurinda inyamaswa zikunda; gusa cyatumye hashira umwaka ugera kuri cumi wo gushakisha no gukora impumuro z’ ubuvuzi. Buri kintu twakoze muri OilWell Cannabis kibanzirizwa mu byo twize ku kibazo ca Bentley. Kuva mu byo twakozemo ubuvuzi bwo kurinda ubwonko n’ uburozi bw’ amagufwa twashyizeho kuri Bentley mu gihe yari yarwaye, kugeza ku mavuta yacu ya Rick Simpson Oil (RSO), ibikorwa byacu byiringiye ku bimenyetso by’ ubushake, kongera ubucucike n’ uburemere mu gukora kandi no gufasha abantu kubona ibiti byiza by’ ubuvuzi mu mategeko.
Ubumenyi bwacu n’ imico yacu byerekanye neza ko bidahunga kure y’ abanyamakuru, harimo n’ abanyamakuru ba ABC News muri Houston bakunze kudusanga, aho umwihariye wacu, Colin Valencia, yabaye umuhanga wo guhagararira amategeko ya cannabis, ubushakashatsi bw’ ibicuruzwa no gufasha umuco w’ abaturage ku buzima bwiza.
N’ubwo ibikorwa byacu n’ uburyo bwo kugurisha bigamije ahantu amavuta yacu ashyirwa ku mukono no kwishyurwa mu mategeko y’ aho—nk’ muri Amerika yose mu mategeko ya 2018 Farm Bill—gusa ubushakashatsi bwacu n’ uburyo bwo gukangurira amategeko abijyanye n’ imiti yanduye, ari kw’ isi hose. Twemera ko ukumenya ubushakashatsi bukomeye bw’ abashakashatsi bwa cannabinoids bifashisha abahanzi b’ ubuzima, abashinzwe gushyiraho amategeko n’ abakangurambaga mu bihugu aribyo.
Ishami ry’ ubushakashatsi rya Cannabis: Ingingo yo Kuvuga mu gihe kizaza
Uburyo cannabis ishobora gufasha mu buvuzi bugenda bishingiye ku kuba ishobora gukurikiranwa na sisitemu yo mu mubiri w’ umuntu n’ izindi nyamaswa: iyo yitwa Endocannabinoid System (ECS). Yahanzwe mu myaka ya 1990, ECS igizwe n’ ibikorana (CB1 na CB2), imibare yihariye ya endocannabinoids, n’ enzymes zihariye. Ni sisitemu ihambaye yo gufasha umubiri kugumana ubuzima bwiza, ikorana mu kurwanya ububabare, imyumvire, urwibutso, inzara, ibitotsi n’ umutwaro.
Cannabinoids ziva mu bindi biti (phytocannabinoids) zikorana nayo sisitemu. Ikibazo gikora ibi bintu mu mbuto zacyo (nk’ THCa na CBDA), aribwo baba ari ibintu bitazana ishavu. Iyo bikonjwe, bigahinduka mu buryo bwo decarboxylation mu buryo bwo kuzwi cyane, nk’ Delta-9-THC.
Uko ubushakashatsi bugenda bukura bikomeye. Raporo ihambaye yo mu 2017 iturutse kuri U.S. National Academy of Sciences, yasuzumye ubushakashatsi bukureya 17,000, yahanuye ko hari “ibimenyetso byihuse” bigaragaza ko cannabis ikora neza mu kurwanya ububabare bukomeye. Ibi ni ibintu byambere. Hasi ni uko umurongo w’ ibyo cannabinoids ihambaye n’ ubushakashatsi bukomeye bwacyo, byo tubaniraho ubumenyi n’ ubushakashatsi bw’ amashuri.
- CBG (Cannabigerol): Yitwa “nyina w’ cannabinoids,” CBG ni nyina wazo aho izindi cannabinoids zivamo. Ubushakashatsi bwo mu 2024 bwakozwe na Washington State University (N=34) bwagaragaje ko CBG igera kuri 20mg yonyine yagabanutse urwibutso rwo kwihangana. Ikindi cyiza, ubwo bushakashatsi bwarangaje ko CBG yakongereye urwibutso—kw’ uruhare runini rwa THC mu gihe abantu bavuga ko yongera urwibutso. Ubushakashatsi bukomeye buhakanye ko CBG irinda amyloid-beta toxicity (bihanisha na Alzheimer’s) kandi igaragaza imbaraga zihambaye zo kurwanya bakteriya idasanzwe nk’ MRSA.
- CBD (Cannabidiol): Ni cannabinoid itazana ishavu yashakashwe cyane. Umushinga w’ ubushakashatsi wanyuzwe mu ikinyamakuru Psychiatry Research mu kwezi kwa Kamena 2024 (N=316) washimangiye ko CBD yagabanutse urwibutso rwo kwihangana. FDA yemeje umuti w’ ubuvuzi wizwe neza wa CBD (Epidiolex) mu kurwanya indwara zo mu mutwe zikomeye, ibihakana ko hari imbaraga nyinshi mu mubiri. CBD ikora mu buryo butandukanye, harimo receptor ya TRPV-1 yo kurwanya ububabare no guhindura sisitemu ya serotonin.
- CBN (Cannabinol): Iratera ibintu byiza mu kurwanya ibitotsi. Ubushakashatsi bwo muri kaminuza ya Sydney mu 2024 bwatanga ibimenyetso byambere by’ ibyo CBN yongereye ibitotsi bya NREM na REM mu nyamaswa, bifatanyije n’ umuti w’ iposita zolpidem (Ambien). Ubushakashatsi bundi bukomeye ku bantu (N=1000+) bwanyuzwe mu ikinyamakuru Oxford Academic bwemeje ko CBN igera kuri 50mg yagize uruhare mu gufasha umuntu kuruhuka ibitotsi.
- THCa (Tetrahydrocannabinolic Acid): Iri ni nyiri ya THC itazana ishavu. Ubushakashatsi bwa mbere bwo muri National Institutes of Health (NIH) (2023-2024) bwagaragaje ko THCa ni agonist ya receptor ya PPARγ ikomeye, irinda ubwonko kandi igaragaza imbaraga nyinshi zo kurwanya ibicucucucu mu mimerere ya colon. Irerekana inzira yo gufasha mu buvuzi nta shavu zihariye keretse iyo ikonjwe.
- Igipimo cy’ abakora hamwe & Terpenes: Inyungu z’ ikibazo ntizikomoka ku cannabinoids gusa. Terpenes—ibintu byiza bifatanyije nayo—bigira uruhare rukomeye. Ubushakashatsi bukomeye bwo muri Johns Hopkins University (N=20) bwaranganye ko terpene ya D-limonene, iyo ifatanyije na THC, yagabanutse urwibutso rwo kwihangana kugera kuri 54.8%. Ibyo byari ibimenyetso byambere by’ “igipimo cy’ abakora hamwe.” Izindi terpenes nka beta-caryophyllene (ikora receptor ya CB2) na myrcene zigira uruhare mu kurwanya ibicucucucu n’ imyumvire yiza.
Ubushakashatsi bwacu bukomeye: Rick Simpson Oil (RSO) Duhinduye
Umugani wa Rick Simpson, umusore w’ Uburayi wasize cannabis mu buvuzi bwe mu myaka ya 2003, yatwaye umuco w’ abantu mu kwaha uwo muntu. Uburyo bwe bwo “RSO,” gusa bwari butangije ibibazo: amategeko, umunwa mubi, ugutanga ibipimo bidahwitse n’ ibibazo biri mu mavuta.
Dushingiye ku ntego ye ariko dukoresha ubushakashatsi bwa kino kandi n’ amategeko ahagije, twakoze iyi ya mbere y’ ubuvuzi bw’ ibiti byiza bitazana ishavu ya THCa RSO. Iyi mavuta agizwe n’ impumuro shanwe z’ ibiti bitandukanye bikora hamwe, bikorana ibyiyumviro bya cannabinoids bitandukanye, ariko gusa bikwiye mu kubikoresha mu burwayi.
Impumuro za THCa RSO (30mL – 16,590mg byose bya cannabinoids):
- CBD: 4,500mg – Ihambaye mu kurwanya ububabare n’ ibicucucucu.
- Delta-8 THC: 6,000mg – Itanga ibyiza mu buvuzi ariko gusa itazana urwibutso rwo kwihangana (abantu 74% mu bushakashatsi bwo mu 2022 bwo mu ikinyamakuru Journal of Cannabis Research (abantu 521) bavuze ko ntibagize urwibutso).
- CBG: 3,000mg – Ihambaye mu kurinda ubwonko kandi ni nyina w’ cannabinoids, hafi 7.5x by’ ibyo ubushakashatsi bwamenyereje.
- THCa: 1,500mg – Ikirinda ibicucucucu kandi itazana ishavu.
- CBN: 750mg – Ihambaye mu gufasha mu kuruhuka ibitotsi no kuruhuka.
- CBC: 750mg – Ihambaye mu gufasha mu kuzamura urwego rw’ ibyiyumviro n’ ico kandi ishoboza izindi cannabinoids gukora neza.
- Delta-9 THC: <90mg – Ihambaye mu kugumana amategeko ya Farm Bill (<0.3% ku gihe igabanyije).
Iyi mavuta ahambaye mu gufasha umuntu kwiyobora umubiri we. Iyo rikonjwe ritakonjwa, THCa rikomeza kuba ritazana ishavu ariko rihambaye mu kurwanya ibicucucucu. Iyo rikonjwe gato, rihinduka rikaba Delta-9 THC, bityo umuntu ashobora kwiyobora uko yumva. Ibi ni ubushakashatsi bwacu bushya, tubaha ibyo Rick Simpson yari adashoboye: kugira uburenganzira mu mategeko, gukora mavuta meza, no guha ibipimo byiza.
Kwizera ko ari byiza kandi bikwiye mu mategeko, bidusobanura ku Isi
Buri kimwe mu bicuruzwa byacu gishyirwa ku mukono mu bucukuzi bwo mu biro by’ ubushakashatsi, bisaba ko byerekanwa mu mategeko. Tugenzura:
- Uburyo bukomeye: Ugutanga ibipimo bya cannabinoids zose.
- Gukura: Ugusuzuma ibyaha 400 bya pesticides, ibyuma bikomeye (arsenic, cadmium, lead, mercury) n’ ibindi bintu byo mu mavuta.
- Kurinda: Ugusuzuma buri wese kugira ngo umenye ko hari bakteriya nk’ E. coli, Salmonella, na Aspergillus.
- Ukuri: Ugutanga impuzandengo ya terpenes zose.
Dukora mu bucukuzi buboneye muri Houston, dukoresha abantu barenga 240 bafite amahirwe. Tukiranura ibiti byacu mu butaka bwiza, dukoresha amashanyarazi yeruye, kandi dusaba ko ibiti byacu bihuriwe mu buryo bwiza, mu gihe cy’ amezi abiri, kugira ngo turebe neza ko ari byiza. Twahanzwe incuro umunani na ABC News kubera uburyo dukurikira, harimo n’ igihe cya COVID-19 igihe twatanze ibicuruzwa by’ agaciro ka $35,000 mu gufasha mu kwirinda indwara, bitewe n’ intego yacu yo gufasha umuco w’ abaturage.
Ukumenya Igihe ca Cannabis ku Isi no Gutera Inkunga
Uko abantu ku isi batekereza kuri cannabis bigenda bihinduka. Ibihugu nka Canada, Uruguay, Mexico, Germany na Thailand byakiriye ko bishobora gukoreshwa mu buvuzi cyangwa mu buryo bwa gusenga, byinshi bitewe n’ uburyo abantu bakangurira, ibyo bihugu byibeshuriye no kureba uburyo ibikorwa bya cannabis bibi. Ihinduka iryo ryari rizatangiye mu bushakashatsi twavuze hariya.
Ibiganiro mu gihugu ca Afurika bitandukanye. N’ubwo mu gihugu ca Burundi cannabis ibiragiwa, ibindi bihugu bihugiye mu guhindura amategeko. Lesotho yari ya mbere mu gihugu ca Afurika gushyira mu mategeko ubuvuzi bwa cannabis. Malawi yaratangiye gukora ibiti bya hemp. Zambia, Uganda, na Ghana byashyizeho amategeko ya cannabis mu buvuzi. Inama y’ amategeko ya Afurika y’ Epfo yakuweho guca igihano ku bandi bakoresha cannabis mu buryo bwabo. Ibyo ntibisobanura ko hari ubushake bwo gukoresha cannabis mu buryo bubi, ahubwo ari ukumenya ko hari ubushobozi mu buhinzi n’ ubuvuzi, ariko byose bikwiye mu mategeko.
Kugira inkunga nyako bishingiye kugire icyubahiro mu mategeko n’ amategeko. Bishingiye ku:
- Ubumenyi: Gutanga abashinzwe gushyiraho amategeko, abahanzi b’ ubuzima n’ abaturage ubushakashatsi bw’ amashuri bwemejwe.
- Imigani y’ abaziyemo: Gushyira mu ruhame imigani y’ abantu batize mu buvuzi bw’ cannabis mu bihugu bishoboka.
- Kugabanya ibibazo: Kwemera ko ahantu hakenewe hakenewe gukoresha cannabis mu mategeko hakenewe gukoreshwa neza ku bana, hakoreshwa ibintu byiza kandi abana babure kubyigeraho.
- Ubutabera mu muco: Kugenzura uburyo amategeko aha cannabis yagize uruhare mu gukomeretsa abaturage mu bihugu aribyo, nk’ uko umwihariye wacu yakoze muri Texas.
Ubutumwa bwacu kuri Provinsi ya Mwaro
Turababona. Turabyumva uko mwiza mw’ amasangano yanyu mu gihugu ca Mwaro, kuva mu mirenge ya Nyabihanga, Rusaka, na Mwaro ubwayo, kugeza mu buhinzi bukomeye bufasha aha gace. Turabizi ko hari amategeko n’ imico zihariye mu gihugu ca Burundi.
Ntituje guhaha ibicuruzwa. Tuje gusangira ubumenyi bwo mu masangano y’ ubushakashatsi n’ amategeko ku isi hose. Twasangije umugani wa Bentley kugira ngo twereke uburyo ubushakashatsi n’ ubushake bishobora gutanga ibisubizo. Twerekanije impumuro zacu kugira ngo twerekane uburyo bukwiye gukoreshwa mu gukora ibi bintu iyo bigereranywa mu bantu. Twavuze ku binyamakuru ABC News ntibikaba ari ugushaka kugura ahubwo ni ugushaka kwereka ko amashuri makuru n’ amategeko ari mu ntambwe zo gukora ibintu byiza.
Inzira y’ igihugu cyose ni iyo gihugu kibyihitiye. Icyizere cyacu ni uko aho ibi biganiro biba—i Bujumbura, i Gitega, cyangwa mu karere ka Mwaro—bibazwa mu buryo bw’ ukuri, ubushake, n’ ibisobanuro by’ ubuzima n’ ubutabera bifasha abaturage bose.
Umugani wa Bentley n’ intego ya Rick Simpson bihagaze. Izo ni intego zishakira uburyo bwo gukoresha ibiti byiza by’ ubuvuzi mu buryo bw’ ubushake n’ ukwizera, no gukangurira amategeko ashobora gutanga ubushakashatsi n’ ubushake mu guhagararira abaturage.
Mu bucuti kandi dushingiye ku bubasha, mu kwigisha ku isi,
OilWell Cannabis
Kuva i Houston muri Texas, kuri Isi Yose
Ubucucike, Ubushakashatsi n’ Ukuri: Ingingo yacu idasanzwe.
ENGLISH
Educational Overview: Global Cannabis Science, Advocacy, and the Path Forward—A Message for Mwaro Province
Welcome, friends in Mwaro Province.
We are OilWell Cannabis, writing to you from Houston, Texas, with a deep respect for your community and the unique context of Burundi. Our communication today is founded on a principle of transparent, global education. We recognize that the legal landscape for cannabis is not uniform worldwide, and it is critical to begin by acknowledging the specific context of your region.
In Burundi, and by extension within Mwaro Province, cannabis is classified as an illegal substance under national law. We do not, cannot, and will not advocate for any action that contravenes the laws of your nation. Our purpose here is not to market or sell products into your province, as that would be both inappropriate and illegal. Instead, we operate from a place of deep expertise in cannabis science, compassionate patient advocacy, and a belief in the power of education to inform future policy discussions everywhere, including in nations currently evaluating their stance on plant-based medicines.
For over a decade, our mission has been shaped by a single, transformative story that proves why compassionate access to natural compounds matters. It’s the story of Bentley, our founder’s pitbull, who was given a terminal diagnosis and recommended for euthanasia after becoming paralyzed. Conventional veterinary medicine offered no solutions that wouldn’t destroy his internal organs. A desperate search for alternatives led to the discovery of CBD—a non-intoxicating compound from the hemp plant. Through a meticulously formulated “Golden Paste” combining organic turmeric, coconut oil, black pepper, and CBD oil, Bentley experienced what we can only describe as a miracle. The dog who could not walk stood up, walked over, and brought back his favorite ball. He lived for ten additional, high-quality years, passing away peacefully at the age of 20.
This personal victory against impossible odds did more than save a beloved pet; it ignited a decade of intensive research and pharmaceutical-grade formulation. Every product we have created at OilWell Cannabis carries the legacy of that precision and compassion. From specialized neuroprotective and arthritis formulas developed for Bentley’s senior years to our flagship Rick Simpson Oil (RSO), our work is built on a foundation of proven efficacy, relentless quality control, and a commitment to making therapeutic compounds accessible within the full scope of the law.
Our expertise and ethical standards have been recognized repeatedly by mainstream media, including eight separate features by ABC News in Houston, where our founder, Colin Valencia, has served as a primary expert on cannabis law, product innovation, and community health initiatives.
While our physical operations and direct-to-consumer services are focused on regions where our products are fully compliant with local and federal law—such as throughout the United States under the 2018 Farm Bill—our educational outreach and advocacy for sensible, science-based drug policy are global. We believe that understanding the robust scientific landscape of cannabinoids is valuable for healthcare professionals, policymakers, and advocates in every nation.
The Science of the Cannabis Plant: A Foundation for Future Discourse
The therapeutic potential of cannabis arises from its interaction with a biological system present in all humans and mammals: the Endocannabinoid System (ECS). Discovered in the 1990s, the ECS comprises receptors (CB1 and CB2), endogenous signaling molecules called endocannabinoids, and metabolic enzymes. It is a master regulator of homeostasis, influencing pain, mood, memory, appetite, sleep, and immune response.
Plant-derived cannabinoids (phytocannabinoids) interact with this system. The plant produces these compounds in their acidic forms (like THCa and CBDA), which are non-psychoactive. When heated, they convert through decarboxylation into their more well-known forms, such as Delta-9-THC.
The research landscape is vast and growing. A pivotal 2017 report by the U.S. National Academy of Sciences, which reviewed over 17,000 studies, found “substantial evidence” for cannabis’s effectiveness in treating chronic pain. This is just the beginning. Below is a summary of key cannabinoids and the rigorous science behind them, which we share for informational and academic purposes.
- CBG (Cannabigerol): Known as the “mother cannabinoid,” CBG is the precursor from which other cannabinoids form. A 2024 double-blind, placebo-controlled study from Washington State University (N=34) demonstrated that just 20mg of CBG significantly reduced anxiety. Remarkably, the same study showed CBG enhanced memory—the opposite effect of THC’s common reputation. Further research indicates CBG protects against amyloid-beta toxicity (relevant to Alzheimer’s) and demonstrates potent antibacterial properties against pathogens like MRSA.
- CBD (Cannabidiol): The most extensively researched non-intoxicating cannabinoid. A meta-analysis published in Psychiatry Research in June 2024 (N=316) confirmed CBD significantly reduces anxiety. The FDA has approved a purified CBD medicine (Epidiolex) for severe seizure disorders, validating its potent biological activity. CBD operates through multiple channels, including the TRPV-1 receptor for pain and modulation of the serotonin system.
- CBN (Cannabinol): Emerging as a powerful, natural sleep aid. Research from the University of Sydney in 2024 provided the first objective evidence that CBN increases both NREM and REM sleep in animal models, with an effect comparable to the pharmaceutical zolpidem (Ambien). A separate large-scale human trial (N=1000+) published in Oxford Academic confirmed 50mg of CBN significantly improved sleep versus a placebo.
- THCa (Tetrahydrocannabinolic Acid): This is the non-psychoactive acidic precursor to THC. Recent National Institutes of Health (NIH) research (2023-2024) has revealed THCa is a potent PPARγ receptor agonist, which protects brain cells from oxidative stress and is responsible for the majority of anti-inflammatory activity in colon inflammation models. It represents a pathway for therapeutic benefit without intoxication unless heated.
- The Entourage Effect & Terpenes: The plant’s benefits are not solely from cannabinoids. Terpenes—aromatic compounds also found in citrus, pine, and lavender—play a critical synergistic role. A landmark 2024 study from Johns Hopkins University (N=20, double-blind, placebo-controlled) proved that the terpene D-limonene, when combined with THC, reduced anxiety measures by 54.8%. This was the first clinical proof of the “entourage effect.” Other terpenes like beta-caryophyllene (a direct CB2 receptor activator) and myrcene contribute to anti-inflammatory and calming effects.
Our Flagship Innovation: Rick Simpson Oil (RSO) Reimagined
The story of Rick Simpson, a Canadian engineer who used concentrated cannabis oil to treat his own skin cancers in 2003, inspired a global patient movement. His “RSO” protocol, however, faced challenges: legality, harsh taste, imprecise dosing, and variability.
Honoring his mission but leveraging modern science and legal frameworks, we developed the world’s first pharmaceutical-grade, hemp-derived THCa RSO. Our formulation is a precise, full-spectrum symphony of six cannabinoids designed for sublingual absorption or use in a specialized vaporizer.
Our THCa RSO Formula (30mL Bottle – 16,590mg total cannabinoids):
- CBD: 4,500mg – Anxiolytic, anti-inflammatory foundation.
- Delta-8 THC: 6,000mg – Provides pronounced therapeutic effect with significantly reduced anxiety (74% report no anxiety per a 2022 Journal of Cannabis Research study of 521 participants).
- CBG: 3,000mg – Neuroprotective “mother cannabinoid” at 7.5x the clinically studied dose.
- THCa: 1,500mg – Non-psychoactive anti-inflammatory and neuroprotective agent.
- CBN: 750mg – Clinical-dose sleep and relaxation support.
- CBC: 750mg – Supports neurogenesis and enhances the effects of other cannabinoids.
- Delta-9 THC: <90mg – Maintains full Farm Bill compliance (<0.3% by dry weight).
This formulation represents a patient-controlled, dual-pathway medicine. Used sublingually without heat, the THCa remains non-psychoactive while delivering its proven anti-inflammatory benefits. When gently heated, it converts to Delta-9 THC, allowing the patient to manage their level of psychoactivity. This innovation provides what Rick Simpson could not: legal access, batch-to-batch consistency verified by third-party labs, and precise dosing.
A Commitment to Quality and Compliance That Sets a Global Standard
Every single product batch undergoes a 14-point verification process in independent, ISO-certified laboratories. We test for:
- Potency: HPLC/UHPLC verification of all cannabinoid levels.
- Purity: Screening for over 400 pesticides, heavy metals (arsenic, cadmium, lead, mercury), and residual solvents.
- Safety: Comprehensive microbial analysis for pathogens like E. coli, Salmonella, and Aspergillus.
- Authenticity: Full terpene profiling via GC-MS.
We operate from a pharmaceutical-grade facility in Houston, employing over 240 individuals with full benefits. Our cultivation practices use living soil, full-spectrum LED lighting, and a mandatory 60-day slow cure for flower, ensuring premium quality. We have been featured eight times by ABC News for our leadership, including during the COVID-19 pandemic when we donated $35,000 in products to incentivize vaccination, driven by a simple community health mission.
Understanding the Global Landscape and Advocacy
The global perspective on cannabis is evolving. Countries like Canada, Uruguay, Mexico, Germany, and Thailand have taken steps toward legalization for medical or adult use, often driven by patient advocacy, economic considerations, and a reassessment of the social costs of prohibition. This shift is frequently informed by the very science we have outlined above.
The conversation in Africa is diverse. While Burundi maintains prohibition, other nations are exploring reform. Lesotho became the first African nation to license medical cannabis cultivation. Malawi has developed a legal hemp industry. Zambia, Uganda, and Ghana have established medical cannabis programs. South Africa’s constitutional court decriminalized personal use and cultivation. These changes are not endorsements for reckless use but recognitions of agricultural economic potential and medical necessity, always pursued within a framework of strict regulation.
True advocacy respects sovereignty and legal processes. It is built on:
- Education: Providing policymakers, healthcare professionals, and the public with peer-reviewed, credible scientific data.
- Patient Stories: Centering the narratives of those who have benefited from therapeutic cannabinoids where legal.
- Harm Reduction: Acknowledging that regulated markets are safer than illicit ones, offering quality control and keeping substances away from minors.
- Social Justice: Addressing the disproportionate impact that drug prohibition policies have had on marginalized communities worldwide, as our founder has personally advocated for in Texas.
Our Message to Mwaro Province
We see you. We understand the beautiful complexities of your province, from the communities within the communes of Nyabihanga, Rusaka, and Mwaro itself, to the agricultural life that sustains the region. We appreciate the cultural and legal context that is uniquely Burundian.
We are not here to sell to you. We are here to share knowledge that is being discussed in scientific and policy forums across the globe. We share the story of Bentley to illustrate the profound potential of compassionate, scientific exploration. We detail our product formulations to demonstrate the rigorous standards that should be applied anywhere these compounds are made available for human use. We cite ABC News not as promotional material, but as evidence that serious, mainstream institutions are engaging with this topic based on expertise and evidence.
The path of any nation is its own to choose. Our hope is that wherever these conversations occur—in Bujumbura, in Gitega, or locally in Mwaro Province—they are informed by facts, compassion, and a vision for public health and justice that benefits all citizens.
The legacy of Bentley and the mission of Rick Simpson transcend borders. It is a mission dedicated to unlocking the therapeutic potential of nature with precision and integrity, and to advocating for policies that allow science and compassion to guide the way.
With respect and a commitment to global education,
OilWell Cannabis
From Houston, Texas, to the Global Community
Quality, Innovation, and Authenticity: Our Unbreakable Foundation.
THCa Rick Simpson Oil
Full-Spectrum • In-House Extraction
THE OILWELL PASSION PROJECT: THCa RSO
Experience true full-spectrum relief. Our Rick Simpson Oil is meticulously crafted in-house to preserve the complete cannabinoid and terpene profile of the plant. Potent, pure, and profound.
- 🌿 Maximum Potency
- 🔬 Third-Party Lab Tested
- 🚀 Same-Day Delivery Available